These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 28779373)

  • 1. Ethical Considerations of Patient-Funded Research for Multiple Sclerosis Therapeutics.
    Amezcua L; Nelson F
    Neurotherapeutics; 2017 Oct; 14(4):945-951. PubMed ID: 28779373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Research Translation and Emerging Health Technologies: Synthetic Biology and Beyond.
    Chan S
    Health Care Anal; 2018 Dec; 26(4):310-325. PubMed ID: 27942987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Principles for the ethical analysis of clinical and translational research.
    Gelfond JA; Heitman E; Pollock BH; Klugman CM
    Stat Med; 2011 Oct; 30(23):2785-92. PubMed ID: 21751225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethics and regulatory considerations for the clinical translation of somatic cell human epigenetic editing.
    Zeps N; Lysaght T; Chadwick R; Erler A; Foo R; Giordano S; San Lai P; Schaefer GO; Xafis V; Chew WL; Sugarman J
    Stem Cell Reports; 2021 Jul; 16(7):1652-1655. PubMed ID: 34214486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping the Ethics of Translational Genomics: Situating Return of Results and Navigating the Research-Clinical Divide.
    Wolf SM; Burke W; Koenig BA
    J Law Med Ethics; 2015; 43(3):486-501. PubMed ID: 26479558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The translational potential of research on the ethical, legal, and social implications of genomics.
    Burke W; Appelbaum P; Dame L; Marshall P; Press N; Pyeritz R; Sharp R; Juengst E
    Genet Med; 2015 Jan; 17(1):12-20. PubMed ID: 24946153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient perspectives on physician conflict of interest in industry-sponsored clinical trials for multiple sclerosis therapeutics.
    Solomon AJ; Klein EP; Corboy JR; Bernat JL
    Mult Scler; 2015 Oct; 21(12):1593-9. PubMed ID: 25716879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ISSCR's Guidelines for Stem Cell Research and Clinical Translation: Supporting development of safe and efficacious stem cell-based interventions.
    Turner L
    Stem Cell Reports; 2021 Jun; 16(6):1394-1397. PubMed ID: 34048693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Swiss Multiple Sclerosis Registry (SMSR): study protocol of a participatory, nationwide registry to promote epidemiological and patient-centered MS research.
    Steinemann N; Kuhle J; Calabrese P; Kesselring J; Disanto G; Merkler D; Pot C; Ajdacic-Gross V; Rodgers S; Puhan MA; von Wyl V;
    BMC Neurol; 2018 Aug; 18(1):111. PubMed ID: 30103695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Participatory decision making in multiple sclerosis.
    Solari A
    Eur J Neurol; 2009 Jan; 16(1):3-4. PubMed ID: 19087141
    [No Abstract]   [Full Text] [Related]  

  • 11. Shared decision-making in multiple sclerosis.
    Colligan E; Metzler A; Tiryaki E
    Mult Scler; 2017 Feb; 23(2):185-190. PubMed ID: 27663871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethical implications of disparities in translation genomic medicine: from research to practice.
    Suleman M; Parker MJ; Qureshi N
    J Med Ethics; 2024 Jun; 50(7):435-436. PubMed ID: 38906545
    [No Abstract]   [Full Text] [Related]  

  • 13. The bench is closer to the bedside than we think: Uncovering the ethical ties between preclinical researchers in translational neuroscience and patients in clinical trials.
    Yarborough M; Bredenoord A; D'Abramo F; Joyce NC; Kimmelman J; Ogbogu U; Sena E; Strech D; Dirnagl U
    PLoS Biol; 2018 Jun; 16(6):e2006343. PubMed ID: 29874243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving health care delivery for persons with multiple sclerosis.
    Kraft GH
    Phys Med Rehabil Clin N Am; 1998 Aug; 9(3):703-15, viii-ix. PubMed ID: 9894119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethical issues in multiple sclerosis.
    Nelson RF
    Semin Neurol; 1997; 17(3):227-34. PubMed ID: 9311064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physician compensation for industry-sponsored clinical trials in multiple sclerosis influences patient trust.
    Klein E; Solomon AJ; Corboy J; Bernat J
    Mult Scler Relat Disord; 2016 Jul; 8():4-8. PubMed ID: 27456867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethics and stem cell therapeutics for cardiovascular disease.
    Sugarman J
    Prog Cardiovasc Dis; 2007; 50(1):1-6. PubMed ID: 17631433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Setting Global Standards for Stem Cell Research and Clinical Translation: The 2016 ISSCR Guidelines.
    Daley GQ; Hyun I; Apperley JF; Barker RA; Benvenisty N; Bredenoord AL; Breuer CK; Caulfield T; Cedars MI; Frey-Vasconcells J; Heslop HE; Jin Y; Lee RT; McCabe C; Munsie M; Murry CE; Piantadosi S; Rao M; Rooke HM; Sipp D; Studer L; Sugarman J; Takahashi M; Zimmerman M; Kimmelman J
    Stem Cell Reports; 2016 Jun; 6(6):787-797. PubMed ID: 27185282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Translational research-the need of a new bioethics approach.
    Hostiuc S; Moldoveanu A; Dascălu MI; Unnthorsson R; Jóhannesson ÓI; Marcus I
    J Transl Med; 2016 Jan; 14():16. PubMed ID: 26767499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New partnership pumps pound 1m into stem cell research for multiple sclerosis.
    Watts G
    BMJ; 2010 Jan; 340():c292. PubMed ID: 20080823
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.